search button

Beclin‑1 expression is associated with prognosis in a Bcl‑2‑dependent manner in non‑small cell lung cancer

  • Authors:
    • Hailei Du
    • Ling Chen
    • Fangxiu Luo
    • Xueyu Chen
    • Yong Li
    • Qijian Cheng

  • View Affiliations

  • Published online on: July 15, 2020     https://doi.org/10.3892/ol.2020.11870
  • Article Number: 9
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Beclin‑1 and Bcl‑2 expression abnormalities have been confirmed in different types of cancer. As important regulators of autophagy and apoptosis, respectively, these molecules serve a complex role in tumorigenesis. However, limited information is currently available regarding the association between Beclin‑1 and Bcl‑2 in (NSCLC). In the present study, the expression levels of Beclin‑1 and Bcl‑2 were detected in lung cancer tissues, and their prognostic significance was analyzed for NSCLC. A total of 120 patients with lung cancer who underwent surgical resection were included in the present study. Beclin‑1 and Bcl‑2 expression was assessed using immunohistochemistry and their associations with the overall survival (OS) in patients with NSCLC was examined. The expression rate of Beclin‑1 was significantly lower in NSCLC tissues compared with that in adjacent tissues, whereas the expression rate of Bcl‑2 was significantly higher in lung cancer tissues compared with that in adjacent tissues. Additionally, Beclin‑1 and Bcl‑2 protein expression was strongly associated (P<0.05) in NSCLC. Patients with NSCLC with low Beclin‑1 expression were in more advanced stages, with more lymph node metastasis and more poorly differentiated tumors. Similarly, patients with NSCLC with high Bcl‑2 expression were also in a more advanced stage and had more lymph node metastasis. Cox regression analysis revealed that the association between Bcl‑2 expression and survival was not significant, while a multivariate analysis revealed that Beclin‑1 expression was significantly associated with OS. Notably, Beclin‑1 expression was significantly associated with OS only in patients with high Bcl‑2 expression. In conclusion, the present data indicated that the autophagy activity is decreased in NSCLC. Beclin‑1 expression was downregulated, while Bcl‑2 expression was upregulated in NSCLC tissues compared with that in adjacent tissues. Additionally, these two proteins were associated with the occurrence and progression of NSCLC. Beclin‑1 may be a promising prognostic marker for patients with NSCLC with high Bcl‑2 expression. The present findings provided a more accurate prognostic assessment for patients with NSCLC. Furthermore, they may be used to actively follow‑up and promptly treat patients with a poor prognosis, which may benefit a greater number of patients with NSCLC.
View Figures
View References

Related Articles

Journal Cover

October-2020
Volume 20 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 5.7
  • CiteScore Rank: Q2: #139/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.574
  • SCImago Journal Rank (SJR): 0.644
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Du H, Chen L, Luo F, Chen X, Li Y and Cheng Q: Beclin‑1 expression is associated with prognosis in a Bcl‑2‑dependent manner in non‑small cell lung cancer. Oncol Lett 20: 9, 2020.
APA
Du, H., Chen, L., Luo, F., Chen, X., Li, Y., & Cheng, Q. (2020). Beclin‑1 expression is associated with prognosis in a Bcl‑2‑dependent manner in non‑small cell lung cancer. Oncology Letters, 20, 9. https://doi.org/10.3892/ol.2020.11870
MLA
Du, H., Chen, L., Luo, F., Chen, X., Li, Y., Cheng, Q."Beclin‑1 expression is associated with prognosis in a Bcl‑2‑dependent manner in non‑small cell lung cancer". Oncology Letters 20.4 (2020): 9.
Chicago
Du, H., Chen, L., Luo, F., Chen, X., Li, Y., Cheng, Q."Beclin‑1 expression is associated with prognosis in a Bcl‑2‑dependent manner in non‑small cell lung cancer". Oncology Letters 20, no. 4 (2020): 9. https://doi.org/10.3892/ol.2020.11870